Covid-19 roundup: J&J launching new PhII vaccine trials in Europe; Abbott scores $760M testing kit order from HHS
As J&J plans to roll out Phase III testing for its Covid-19 vaccine sometime next month, the big pharma is planning additional Phase II trials in the interim.
J&J will begin mid-stage testing in Spain next week, the country’s health minister said on Friday, as well as in Germany and the Netherlands per a Reuters report. The trial will take two months to complete and enroll about 550 people across the three nations, focusing on healthy individuals aged 18 to 55 in addition to some older than 65.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 92,400+ biopharma pros reading Endpoints daily — and it's free.